Skip to main content
Innovotech Inc. logo

Innovotech Inc. — Investor Relations & Filings

Ticker · IOT ISIN · CA45772U1049 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 165 across all filing types
Latest filing 2026-01-02 Capital/Financing Update
Country CA Canada
Listing TSXV IOT

About Innovotech Inc.

https://innovotech.ca/

Innovotech Inc. is a specialist in antimicrobial and biofilm solutions, recognized as a pioneer in biofilm product development and contract research. The company focuses on providing innovative and practical solutions to medical, agricultural, and industrial problems caused by microbial biofilms. Key offerings include specialized assay kits used globally for growing microbial biofilms in research applications. Through Innovotech Labs, the company provides comprehensive, accredited (GMP and ISO) contract testing services, including analytical, microbiological, and antimicrobial testing. These services target the pharmaceutical, biotechnology, medical device, and nutraceutical industries, aiming to ensure regulatory compliance and product optimization.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a news release announcing the internal corporate restructuring (amalgamation of subsidiaries) of Innovotech Inc. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor does it involve M&A activity with external parties (it is an internal consolidation). As it is a general corporate announcement regarding operational structure that does not fall into the other specialized categories, it is best classified as a general regulatory filing.
2026-01-02 English
Report of exempt distribution (45-106F1).pdf
Share Issue/Capital Change Classification · 1% confidence The document is a 'Form 45-106F1 Report of Exempt Distribution', which is a standard Canadian regulatory filing used by issuers to report the distribution of securities that are exempt from the prospectus requirement. This document details the issuer (Innovotech Inc.), the type of securities distributed (convertible debentures), the distribution date, and the exemption relied upon. As this is a specific regulatory filing regarding capital changes and share issuance, it falls under the 'Share Issue/Capital Change' category.
2025-11-28 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the closing of a $200,000 convertible debenture offering. It details the terms of the financing (interest rate, maturity date, conversion price) and the intended use of proceeds. This falls squarely under the definition of a capital or financing update, as it describes a specific fundraising activity and changes to the company's capital structure.
2025-11-24 English
News release - English.pdf
Transaction in Own Shares Classification · 1% confidence The document is a news release announcing the renewal of a Normal Course Issuer Bid (NCIB) – i.e. the company’s plan to purchase and cancel its own common shares under an issuer bid. This is a direct report of share repurchase activity (own shares transaction). It is not an earnings release, dividend notice, or general regulatory filing but specifically a share buyback announcement. Therefore, it fits the “Transaction in Own Shares” category (Code: POS).
2025-11-05 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a corporate news release titled “INNOVOTECH INC. REPORTS RECORD REVENUE FOR ITS THIRD QUARTER,” providing high‐level quarterly financial results (revenues, net income, YTD figures) and management commentary. It is not a full interim report with detailed statements, but an initial announcement of periodical results, which matches the Earnings Release definition. Q3 2025
2025-11-05 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Consolidated Financial Statements' for Innovotech Inc. for the three and nine-month periods ended September 30, 2025. It contains comprehensive financial statements including the Statement of Financial Position, Statement of Changes in Shareholder's Deficiency, Statement of Operations and Comprehensive Income, Statement of Cash Flows, and detailed Notes to the Consolidated Financial Statements. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. 9M 2025
2025-11-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.